| Pfizer Asked to Stop Selling the Painkiller 'Bextra' |
| 08/12/10 VOA.com |
U.S. health officials asked drugmaker Pfizer to stop selling the painkiller "Bextra" because of concerns that the risks of using the drug outweigh the benefits.
The drug is used by millions of arthritis sufferers.
Officials also asked makers of drugs similar to Bextra to strengthen warnings of possible cardiovascular and gastrointestinal problems.
Above article provided free of charge from www.voanews.com.
----------------------------------------------------------
Comments from Synflex America
----------------------------------------------------------
Searching for an alternative?
Syn-flex® is a breakthrough product in the world of osteoarthritis, joint pain, and cartilage degeneration. While most glucosamine products available today are in capsule or pill form, the liquid glucosamine found in Syn-flex® provides maximum absorption and is beneficial in the treatment of osteoarthritis and eases articular joint pain.
Order Today!
The author's statements have not been evaluated by the Food and Drug Administration and are not provided to diagnose any disease or to suggest that liquid glucosamine and chondroitin will treat, cure, or prevent any disease.
|
|
